For the latest COVID information Click Here.
Updated July 2024
Ixekizumab (brand name: Taltz®) is a medicine for adults with psoriatic arthritis, a type of joint inflammation ofen seen with psoriasis (a skin condition). It is also used for adults with moderate to severe plaque psoriasis that is chronic (lasts for a long time).
Ixekizumab can also treat adults with axial spondyloarthritis, including ankylosing spondylitis, which causes inflammation, pain, and stiffness in the spine.
Ixekizumab works by recognising and binding to an inflammatory protein called Interleukin 17A (IL-17A). In people with psoriatic arthritis and axial spondyloarthritis, the body makes too much IL-17A, leading to stiff and painful joints. Ixekizumab helps reduce inflammation and other symptoms caused by too much IL-17A.
You may notice reduced joint swelling, pain and stiffness, often within the first 8 weeks of starting.
If you stop or delay your ixekizumab treatment, your condition might get worse. Continue on ixekizumab, unless your rheumatologist tells you to stop or if you get side effects (see Side effects). If you stop ixekizumab for any reason, you must contact your rheumatologist. If you don’t, your treatment may no longer be subsidised by Medicare.
Medicines like ixekizumab are very expensive but Medicare usually helps cover the cost. You can use it if you meet certain conditions.
Ixekizumab is injected just under the skin of the thigh or belly. It is best to avoid (if possible) any areas of skin affected by psoriasis. The prefilled autoinjector or syringe should be taken out of fridge 30 minutes before injecting so it can reach room temperature. Do not shake or freeze it. It can be injected by your doctor, nurse, carer, or by you. If injecting yourself, be sure to follow the detailed instructions carefully to ensure the best response. It is important to change the injection site each time.
Give the next injection as soon as you remember and continue to use it as you normally would. Do not inject a double dose to make up for a missed dose. If you have missed more than one dose or are not sure what to do, check with your doctor or pharmacist.
Ixekizumabcomes in a prefilled syringe or pen which has 80 mg of medicine. The usual starting dose is:
This medicine may be used alone or with other arthritis medicines including:
You might experience side effects with your treatment. Tell your doctor if you notice side effects that you think are caused by this medicine. Many side effects disappear when ixekizumab treatment is stopped.
You may have more mild upper respiratory tract infections (common cold, sinus infections), nausea, diarrhoea, cough, and fever. Infections may need treatment and ixekizumab may need to be stopped for a while if you develop infection, so it is important to contact your doctor for advice.
There are some rare but sometimes serious side effects with ixekizumab, including:
Other side effects not listed in this leaflet may also occur. Tell your doctor if you notice any other side effects that you think might be caused by ixekizumab.
If you have an active infection of any kind, treatment with ixekizumab will not be started until the infection is treated gone.
Serious infections such as tuberculosis (TB) are seen rarely, and screening for TB may be needed before treatment begins.
Ixekizumab can affect and be affected by other medicines. You should tell all your doctors about all medicines you are taking or plan to take. This includes over the counter or herbal/natural medicines.
Ixekizumab should not be used while receiving light therapy (PUVA) for psoriasis.
If you need surgery for any reason, you should discuss this with your rheumatologist as some people need to stop taking ixekizumab before surgery
You may drink alcohol while taking ixekizumab. However, if you are also taking methotrexate, you should be cautious about how much alcohol you drink.